Orgenesis Inc. (NASDAQ:ORGS) Short Interest Update

Orgenesis Inc. (NASDAQ:ORGS) was the recipient of a significant increase in short interest in April. As of April 15th, there was short interest totalling 402,500 shares, an increase of 34.3% from the March 31st total of 299,700 shares. Based on an average daily volume of 235,300 shares, the short-interest ratio is currently 1.7 days.

Orgenesis Trading Up 1.1 %

Shares of NASDAQ:ORGS traded up $0.01 on Tuesday, reaching $0.51. The company had a trading volume of 25,999 shares, compared to its average volume of 209,696. Orgenesis has a 52-week low of $0.25 and a 52-week high of $1.50. The firm’s 50 day simple moving average is $0.65 and its 200-day simple moving average is $0.56.

About Orgenesis

Orgenesis Inc, a biotech company, focuses on cell and gene therapies worldwide. It operates through two segments, Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare network consisting of research institutes and hospitals.